Doxycycline has been widely studied for its potential in treating aortic aneurysms due to its ability to inhibit the expression of MMPs, particularly MMP-2 and MMP-9, which are key enzymes involved in the degradation of elastin and collagen in the aneurysmal wall [111]. This evidence concerns the gene ELN and aortic aneurysm.